Venture Certified
| 기술평가보증기업(기금) | 2020-04-22 ~ 2022-04-21 | 20200105033 | 2020-04-22 |
| 벤처투자유형 | 2022-04-22 ~ 2025-04-21 | 20220428010033 | 2020-04-22 |
| 벤처투자유형 | 2025-04-22 ~ 2028-04-21 | 20250422010030 | 2020-04-22 |
Revenue CAGR +5.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 2.2B | 2.3B | 2.0B |
| Operating Profit | -6.0B | -14B | -31B |
| Net Profit | -5.9B | -14B | -31B |
| Total Assets | 29B | 32B | 50B |
| Total Liabilities | 9.6B | 6.4B | 10B |
| Total Equity | 20B | 25B | 40B |
Operating Loss: Op. profit -6B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+24pp YoY)
▲ 4.5%
▲ 73.6%
▲ 75.4%
▲ 92.1%
▲ 55.3%
| Name | Position | Role |
|---|---|---|
| 백태곤 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 강서구",
"ceo_name": "백태곤",
"certificate": [
{
"cert_number": "20200105033",
"changes": "",
"disclosure_date": "2020-04-22",
"first_cert_date": "2020-04-22",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-04-22 ~ 2022-04-21"
},
{
"cert_number": "20220428010033",
"changes": "",
"disclosure_date": "2022-04-28",
"first_cert_date": "2020-04-22",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-04-22 ~ 2025-04-21"
},
{
"cert_number": "20250422010030",
"changes": "",
"disclosure_date": "2025-04-22",
"first_cert_date": "2020-04-22",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-04-22 ~ 2028-04-21"
}
],
"company_name": "㈜아름테라퓨틱스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 174022000,
"cost_of_sales": 32831000,
"current_assets": 4594988000,
"current_liabilities": 946829000,
"gross_profit": 165481000,
"net_income": -3091426000,
"net_income_bs": -3091426000,
"non_current_assets": 415146000,
"non_current_liabilities": 80000000,
"non_operating_expenses": 10145000,
"non_operating_income": 5815000,
"operating_profit": -3087096000,
"revenue": 198312000,
"sga_expenses": 3252577000,
"total_assets": 5010134000,
"total_equity": 3983305000,
"total_liabilities": 1026829000
},
"2023": {
"capital_stock": 174022000,
"cost_of_sales": 32997000,
"current_assets": 2859624000,
"current_liabilities": 576017000,
"gross_profit": 192787000,
"net_income": -1438344000,
"net_income_bs": -1438344000,
"non_current_assets": 330175000,
"non_current_liabilities": 68820000,
"non_operating_expenses": 17000000,
"non_operating_income": 19286000,
"operating_profit": -1440630000,
"revenue": 225784000,
"sga_expenses": 1633417000,
"total_assets": 3189799000,
"total_equity": 2544962000,
"total_liabilities": 644837000
},
"2024": {
"capital_stock": 174022000,
"cost_of_sales": 50988000,
"current_assets": 2731372000,
"current_liabilities": 918749000,
"gross_profit": 170522000,
"net_income": -587462000,
"net_income_bs": -587462000,
"non_current_assets": 187056000,
"non_current_liabilities": 42180000,
"non_operating_expenses": 18118000,
"non_operating_income": 28036000,
"operating_profit": -597380000,
"revenue": 221510000,
"sga_expenses": 767902000,
"total_assets": 2918428000,
"total_equity": 1957499000,
"total_liabilities": 960929000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "499,000,000",
"changes": "499,000,000",
"date": "2021-04-14"
},
{
"amount": "1,999,000,000",
"changes": "1,999,000,000",
"date": "2021-04-14"
},
{
"amount": "1,499,000,000",
"changes": "1,499,000,000",
"date": "2021-04-14"
},
{
"amount": "999,000,000",
"changes": "999,000,000",
"date": "2021-04-14"
},
{
"amount": "1,499,000,000",
"changes": "1,499,000,000",
"date": "2021-04-14"
},
{
"amount": "999,000,000",
"changes": "999,000,000",
"date": "2021-04-14"
},
{
"amount": "1,999,987,000",
"changes": "1,999,987,000",
"date": "2021-04-14"
}
],
"main_products": "항바이러스 치료제",
"phone": "070-8805-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |